China Pharmaceutical Market Overview - Market Research Report On Aarkstore Enterprise

Introduction

Introduction

The Chinese hospital prescription pharma market generated sales of $22.9 billion in 2009, with an annual growth rate of 26.5% between 2008 and 2009. Key growth drivers include Chinas support of foreign direct investment, low operating costs, growing economic wealth and a government stimulus of $125 billion to be spent on healthcare reforms during 20092011.

Scope

Overview of socioeconomic and demographic trends, healthcare system, regulation, pricing and reimbursement and intellectual property position in China

Assesses the size of the Chinese pharmaceutical market by prescribing setting, therapy area, leading brands and by leading companies

Examines the Chinese generics and biosimilars landscape in terms of regulatory issues, level of penetration, key players and degree of brand erosion

Quantifies the R&D and manufacturing infrastructure for the leading pharmaceutical companies, including key metrics and domestic M&A analysis

Report Highlights

The combination of Chinas rising population to 2030, plus the expansion of the elderly population, as a proportion of the total population, will create additional pressure on the government in terms of healthcare provision especially for the elderly.

According to the Ministry of Health, by the end of October 2010, the three public health insurance schemes covered 1,233 million Chinese citizens, accounting for more than 90% of the total population.

Domestic manufacturers dominate the Chinese generics market, accounting for nearly 99% of generics sales of both branded and unbranded generics. The domestic industry has expanded rapidly as companies have improved their manufacturing capacities.

Reasons to Purchase

Evaluate the evolving regulatory landscape and the impact of pricing and reimbursement controls on market access in China

Quantify the size and growth of the prescription pharmaceutical market in China, analyzing key therapy areas, brands and companies

Assess drivers and resistors of generic and biosimilars uptake in China

For some-more information, Great fully visit:

http://www.aarkstore.com/reports/China-Pharmaceutical-Market-Overview-80706.html

by: Aarkstore Enterprise

POST COMMENT

Sidstone, Gray & Partners Portfolio Diversification In Stock Market Investing Kpo Outsourcing Services - A Growing Market 3d Tv Reviews - Clever Way Of Purchasing 3d Tvs Within The Marketplace Opening the Book on Telemarketing Lists Glucose Testing Markets - Aarkstore Enterprise Event Planner - Why Events Marketing And Advertising Must Be Aspect Of The Advertising Approach The Many Debt Collection Software Products The Collections Market Avoiding Acai Berry Scams Rolls Royce AFTERMARKET wheelcovers and hubcaps Short Sales, Reos Or Motivated Sellers, Which Is More Profitable? Google gains search market share in May Acetrader-Daily Market Outlook 9-12-2010 Ktm Launching Its Duke 200 In Indian2wheeler Market Soon.